45.94
전일 마감가:
$45.74
열려 있는:
$45.57
하루 거래량:
1.52M
Relative Volume:
1.11
시가총액:
$9.92B
수익:
$1.98B
순이익/손실:
$83.59M
주가수익비율:
122.83
EPS:
0.374
순현금흐름:
$502.31M
1주 성능:
+1.46%
1개월 성능:
-6.61%
6개월 성능:
+15.86%
1년 성능:
-2.03%
Qiagen Nv Stock (QGEN) Company Profile
QGEN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
QGEN
Qiagen Nv
|
45.94 | 9.92B | 1.98B | 83.59M | 502.31M | 0.374 |
![]()
TMO
Thermo Fisher Scientific Inc
|
479.58 | 181.67B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
193.29 | 139.82B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
656.16 | 52.44B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
126.32 | 36.18B | 6.79B | 1.22B | 1.09B | 4.26 |
![]()
IQV
Iqvia Holdings Inc
|
187.22 | 32.33B | 15.70B | 1.24B | 2.01B | 6.91 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-06-24 | 개시 | Barclays | Overweight |
2025-04-04 | 다운그레이드 | Redburn Atlantic | Buy → Neutral |
2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2025-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2024-12-10 | 업그레이드 | Jefferies | Hold → Buy |
2024-10-17 | 다운그레이드 | HSBC Securities | Buy → Hold |
2024-06-27 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
2023-12-19 | 개시 | Wells Fargo | Equal Weight |
2023-12-13 | 개시 | Wolfe Research | Peer Perform |
2023-12-07 | 업그레이드 | Goldman | Neutral → Buy |
2023-09-12 | 개시 | Robert W. Baird | Outperform |
2023-05-23 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
2022-01-18 | 업그레이드 | DZ Bank | Hold → Buy |
2021-10-15 | 재개 | Cowen | Market Perform |
2021-10-14 | 개시 | Redburn | Buy |
2021-07-14 | 다운그레이드 | Kepler | Buy → Hold |
2021-06-03 | 개시 | Goldman | Neutral |
2020-10-06 | 재개 | BofA Securities | Buy |
2020-09-28 | 업그레이드 | Kepler | Hold → Buy |
2020-08-24 | 업그레이드 | Citigroup | Neutral → Buy |
2020-08-20 | 재개 | JP Morgan | Overweight |
2020-08-17 | 업그레이드 | Berenberg | Hold → Buy |
2020-08-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
2020-08-14 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
2020-03-04 | 다운그레이드 | Berenberg | Buy → Hold |
2020-01-08 | 개시 | Wells Fargo | Equal Weight |
2020-01-07 | 개시 | Citigroup | Neutral |
2019-12-26 | 재개 | BofA/Merrill | Underperform |
2019-11-15 | 개시 | Stifel | Hold |
2019-11-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
2019-11-14 | 업그레이드 | JP Morgan | Underweight → Overweight |
2019-11-14 | 업그레이드 | Kepler | Reduce → Hold |
2019-10-17 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
2019-10-09 | 다운그레이드 | Kepler | Hold → Reduce |
2019-10-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
2019-10-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2019-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
모두보기
Qiagen Nv 주식(QGEN)의 최신 뉴스
Acadian Asset Management LLC Decreases Stock Position in Qiagen N.V. $QGEN - MarketBeat
Aug Analyst Calls: Does Qiagen NV align with a passive investing strategyQuarterly Trade Report & AI Powered Market Entry Ideas - khodrobank.com
Take Profit: Should I set a stop loss on Qiagen NVEarnings Risk Summary & Target Return Focused Stock Picks - khodrobank.com
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Brokerages - MarketBeat
OGT and QIAGEN announce partnership that unlocks a complete sample to report workflow for SureSeq NGS panels - Drug Discovery News
Aug Final Week: Can Qiagen NV sustain its profitabilityQuarterly Earnings Report & Long-Term Growth Plans - khodrobank.com
Stock Analysis: How does Qiagen N.V. score in quality rankingsJuly 2025 Price Swings & Reliable Price Breakout Alerts - khodrobank.com
Qiagen Receives AFM Notification on Barclays’ Shareholdings - TipRanks
Chipmakers Recap: Can Qiagen NV be the next market leaderEarnings Overview Summary & Low Risk Entry Point Tips - khodrobank.com
Pullback Watch: What are Qiagen NVs recent SEC filings showingWeekly Stock Analysis & Safe Entry Trade Reports - خودرو بانک
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Trends Shaping the Automated Microbiology 2025-2030: Revenues to Surge by $4.65 Billion, Totalling $12.52 Billion in 2030 - GlobeNewswire Inc.
Setup Watch: Can Qiagen NV sustain its profitabilityWeekly Gains Summary & Precise Swing Trade Entry Alerts - khodrobank.com
Qiagen N.V. (QGEN) Rolls Out QIAstat-Dx Rise, Expands U.S. Testing Access - Yahoo
AQR Capital Management LLC Boosts Position in Qiagen N.V. $QGEN - MarketBeat
Strs Ohio Purchases New Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. $QGEN Shares Acquired by Voya Investment Management LLC - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $5.42 Million Stock Holdings in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. $QGEN Shares Sold by Rhumbline Advisers - MarketBeat
Weekly Recap: Why is Qiagen NV stock going upStop Loss & Verified High Yield Trade Plans - khodrobank.com
Downgrade Watch: Does Qiagen N.V. have a sustainable dividendJuly 2025 Trends & Safe Entry Zone Identification - خودرو بانک
Risk Check: Is Qiagen N.V. forming a bullish divergenceWeekly Gains Summary & Weekly Watchlist for Hot Stocks - khodrobank.com
What dividend growth rate does Qiagen N.V. offerJuly 2025 Sentiment & Free High Return Stock Watch Alerts - khodrobank.com
Aug PostEarnings: Whats next for Qiagen NV stockJuly 2025 News Drivers & Consistent Return Strategy Ideas - khodrobank.com
VIX Spike: Should I set a stop loss on Qiagen NVTrade Exit Report & Verified Swing Trading Watchlist - khodrobank.com
Qiagen Announces Voting Rights Notification by AFM - TipRanks
AFM Discloses Barclays’ Voting Rights in QIAGEN - TipRanks
Qiagen Announces BlackRock’s Significant Voting Rights - TipRanks
Gains Recap: What hedge funds are buying JW Mays IncJuly 2025 Selloffs & Safe Entry Point Alerts - خودرو بانک
Is Qiagen NV backed by strong institutional buyingJuly 2025 Fed Impact & Precise Entry and Exit Recommendations - خودرو بانک
Breakout Watch: Whats next for Qiagen NV stockDay Trade & Real-Time Market Sentiment Alerts - khodrobank.com
Qiagen N : Baader Conference Investor Introduction - MarketScreener
QGEN Stock Gains From CE-IVDR Certification for QIAstat-Dx Portfolio - TradingView
Barclays’ Significant Stake in QIAGEN Revealed by AFM - The Globe and Mail
Cubist Systematic Strategies LLC Sells 25,043 Shares of Qiagen N.V. $QGEN - MarketBeat
Vident Advisory LLC Buys Shares of 15,040 QIAGEN N.V. $QGEN - MarketBeat
Activist investor Fivespan takes stake in QiagenBloomberg - MSN
Qiagen N.V. (QGEN) Launches QIAseq xHYB Panels for Long-Read Sequencing - Yahoo Finance
Parkman Healthcare Partners LLC Raises Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen secures European CE-IVDR certification for full Qiastat-Dx portfolio - MarketScreener
QGENQIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels - mx.advfn.com
QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio - sharewise.com
QIAGEN Announces Voting Rights Notification by AFM - The Globe and Mail
Qiagen (QGEN) Earns CE-IVDR Certification for Advanced Diagnosti - GuruFocus
Transcript : Qiagen N.V. Presents at Baird Global Healthcare Conference 2025, Sep-10-2025 01 - MarketScreener
Nitorum Capital L.P. Makes New $4.42 Million Investment in Qiagen N.V. $QGEN - MarketBeat
Qiagen Nv (QGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):